The inclusion of multiple sample types—blood leukocytes, NP tissue, and serum—provides a holistic view of VDR activity in LDD patients, allowing for a thorough analysis of both gene expression and protein levels. The gene discussed is VDR; the disease is Lhermitte-Duclos disease.